Cargando…

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy

Diabetic retinopathy (DR) is a leading cause of vision loss with retinal vascular leakage and/or neovascularization. Current antiangiogenic therapy against vascular endothelial growth factor (VEGF) has limited efficacy. In this study, we applied a new technology of comparative ligandomics to diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales:	LeBlanc, Michelle E., Wang, Weiwen, Chen, Xiuping, Caberoy, Nora B., Guo, Feiye, Shen, Chen, Ji, Yanli, Tian, Hong, Wang, Hui, Chen, Rui, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379984/ https://www.ncbi.nlm.nih.gov/pubmed/28330905 http://dx.doi.org/10.1084/jem.20161802

Ejemplares similares

Reticulocalbin-1 Facilitates Microglial Phagocytosis
por: Ding, Ying, et al.
Publicado: (2015)

Hepatoma-Derived Growth Factor-Related Protein-3 Is a Novel Angiogenic Factor
por: LeBlanc, Michelle E., et al.
Publicado: (2015)

Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy
por: Ji, Liyang, et al.
Publicado: (2023)

ABCF1 extrinsically regulates retinal pigment epithelial cell phagocytosis
por: Guo, Feiye, et al.
Publicado: (2015)

Regulatory Peptides from Chromogranin A and Secretogranin II
por: Helle, Karen B.
Publicado: (2010)

Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels
por: Lin, Chun-Chung, et al.
Publicado: (2019)

An antibody against secretogranin I (chromogranin B) is packaged into secretory granules
Publicado: (1989)

Conditional knockout of the secretogranin II gene to reveal biological functions of secretoneurin
por: Leierer, Johannes, et al.
Publicado: (2008)

Secretogranin II influences the assembly and function of MHC class I in melanoma
por: Steinfass, Tamara, et al.
Publicado: (2023)

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye
por: LeBlanc, Michelle E., et al.
Publicado: (2016)

TRPV1, TRPA1, and TRPM8 are expressed in axon terminals in the cornea: TRPV1 axons contain CGRP and secretogranin II; TRPA1 axons contain secretogranin 3
por: Schecterson, Leslayann C., et al.
Publicado: (2020)

Mysterious inhibitory cell regulator investigated and found likely to be secretogranin II related
por: Hart, John E., et al.
Publicado: (2017)

Epitope mapping of an uncertain endogenous antigen implies secretogranin II peptide splicing
por: Howlett, David R., et al.
Publicado: (2019)

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
por: Sundin, Johanna, et al.
Publicado: (2018)

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
por: Pozzi, Ambra, et al.
Publicado: (2008)

Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
por: Røsjø, Helge, et al.
Publicado: (2012)

Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy
por: Popescu, Mihaela, et al.
Publicado: (2018)

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
por: Paine, Suman K., et al.
Publicado: (2017)

Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
por: Brekk, Oeystein R., et al.
Publicado: (2018)

Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
por: Jo, Yunju, et al.
Publicado: (2022)

Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia‐inducible factor‐1α in colorectal cancer
por: Fang, Chao, et al.
Publicado: (2021)

Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364–384))
por: Biswas, Nilima, et al.
Publicado: (2010)

Tuning the Size of Large Dense‐Core Vesicles and Quantal Neurotransmitter Release via Secretogranin II Liquid–Liquid Phase Separation
por: Lin, Zhaohan, et al.
Publicado: (2022)

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
por: Nuñez-Amaro, Carlos D., et al.
Publicado: (2020)

Nature against Diabetic Retinopathy: A Review on Antiangiogenic, Antioxidant, and Anti-Inflammatory Phytochemicals
por: Khazeei Tabari, Mohammad Amin, et al.
Publicado: (2022)

Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson’s disease
por: Wen, Gehua, et al.
Publicado: (2021)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization
por: Seo, Songyi, et al.
Publicado: (2017)

Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway
Publicado: (1985)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
por: Chen, Wuzhen, et al.
Publicado: (2021)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Identification of Calpain Substrates by ORF Phage Display
por: Caberoy, Nora B., et al.
Publicado: (2011)

Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma
por: Fukumoto, Wataru, et al.
Publicado: (2023)

Antiangiogenic effects of catalpol on rat corneal neovascularization
por: Han, Yun, et al.
Publicado: (2018)

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma
por: Chen, Zhuo, et al.
Publicado: (2015)

Multifunctional Heterometallic Ir(III)−Au(I) Probes as Promising Anticancer and Antiangiogenic Agents
por: Redrado, Marta, et al.
Publicado: (2021)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

The Antiangiogenic Effect and Ocular Pharmacology of Novel Modified Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Oxygen-Induced Retinopathy
por: Huang, Wei, et al.
Publicado: (2023)

Antiangiogenic Polyketides from Peperomia dindygulensis Miq
por: Wang, Qi-Wei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8eaa6r9enf1s9tkpcd9i4nhgjm